Articles tagged "Organ Selection/Allocation"

2022 American Transplant Congress
Assessing Safety of Using ECMO-Supported Donors in Abdominal Transplantation
P. J. Altshuler¹, A. P. Shah¹, J. M. Glorioso¹, W. R. Maley¹, A. M. Frank¹, C. B. Ramirez¹, H. Dang¹, S. West², R. Hasz, Jr.², A. S. Bodzin¹
¹Department of Surgery, Thomas Jefferson University, Philadelphia, PA, ²Gift Of Life Donor Program, Philadelphia, PA
*Purpose: Organ donors supported by extracorporeal membrane oxygenation (ECMO) are historically considered high-risk and are judiciously utilized. Here we explore the safety of using organs…
2022 American Transplant Congress
Kidney Allocation System Promotes Racial Equality Not Equity in Access to Deceased Donor Kidney Transplantation
C. Killian¹, B. Shelton¹, P. MacLennan¹, M. McLeod¹, A. Carter¹, R. Reed¹, H. Qu¹, B. Orandi¹, V. Kumar¹, D. Sawinski², J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²Weill Cornell Medical College, New York City, NY
*Purpose: While the 2014 Kidney Allocation System (KAS) reduced deceased donor kidney transplant (DDKT) racial disparities, candidates’ community-level vulnerability has not been considered. The purpose…
2022 American Transplant Congress
National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation
J. I. López, K. Nijhar, J. Mitchell, L. Bowles Zeiser, K. Key, A. Asamoah-Mensah, A. Thomas, R. Haneda, S. K. Romano, J. Huang, A. Massie, A. M. Cameron, D. L. Segev, E. A. King
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: To examine the use of living donor liver allografts in patient’s requiring redo liver transplantation.*Methods: Using data from SRTR 2009-2020, we evaluated the number…
2022 American Transplant Congress
Biopsy Characteristics of Kidneys from a Single Large OPO
S. Bunnapradist¹, T. Seto², A. Cohen², T. Rosenthal¹, G. Danovitch¹
¹David Geffen School of Medicine, Los Angeles, CA, ²One Legacy, Los Angeles, CA
*Purpose: As deceased donor pool have expanded, kidney biopsy has been increasingly used to help determine organ suitability for transplant. There are concerns that biopsy…
2022 American Transplant Congress
Higher Hepatocellular Carcinoma Tumor Burden Score is Associated with Grater Liver Transplant Survival Benefit
H. Liu¹, W. Zhang², M. Di³, H. Lee⁴, R. Cruz¹, X. Wang², C. Kaltenmeier¹, A. Thompson¹, D. Reddy¹, E. Ashwat¹, M. D'Alesio¹, S. Lebowitz¹, S. Tohme¹, D. Geller¹, A. Tevar¹, C. Hughes¹, A. Humar¹, J. Behari⁵, R. Bataller⁵, S. Hariharan⁵, M. Molinari¹
¹Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Mathematics and Statistics, University of Arkansas at Little Rock, Little Rock, AR, ³Medicine, Medical Oncology, Yale University, New Haven, CT, ⁴Biostatistics, Massachusetts General Hospital, Boston, MA, ⁵Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Liver transplantation(LT) is the best treatment option for early-stage hepatocellular carcinoma(HCC) and cirrhosis. However, patients with various tumor burdens receive identical listing priority, despite…
2022 American Transplant Congress
Early Impact of the Mission Act on Utilization of Veterans Affairs Transplant Centers
J. C. Walker¹, C. Roumie², I. D. Feurer³, R. Forbes⁴
¹General Surgery, Vanderbilt University Medical Center (VUMC), Nashville, TN, ²Internal Medicine, VUMC, Nashville, TN, ³Surgery and Biostatistics, VUMC, Nashville, TN, ⁴VUMC, Nashville, TN
*Purpose: The Veterans Affairs (VA) Maintaining Systems and Strengthening Integrated Outside Networks (MISSION) Act of 2018 was implemented in 2019 to increase veteran access to…
2022 American Transplant Congress
Resource Expenditure in the Evaluation of Older Donors for Heart Transplant: An Impediment to Donor Pool Expansion?
B. Wayda¹, J. G. Zaroff², N. Neidlinger³, P. Geraghty⁴, R. P. Wood⁵, J. Nieto⁵, T. C. Pearson⁶, B. Nicely⁷, K. K. Khush¹
¹Stanford University School of Medicine, Stanford, CA, ²Kaiser Permanente Northern California, Oakland, CA, ³University of Wisconsin School of Medicine, Madison, WI, ⁴Donor Network of Arizona, Tempe, AZ, ⁵LifeGift, Houston, TX, ⁶Emory University School of Medicine, Atlanta, GA, ⁷Gift of Life Michigan, Ann Arbor, MI
*Purpose: Using older donors for heart transplant (HT) could alleviate donor scarcity but the resource implications of this strategy - and whether evaluation of older…
2022 American Transplant Congress
Kidney Transplant Professionals’, Recipients’ and Caregivers’ Perspectives on the Use of Precision Medicine in Kidney Transplantation
F. Ballesteros Gallego¹, A. Affdal¹, M. Malo², R. Sapir-Pichhadze³, M. Fortin¹
¹CRCHUM, Montreal, QC, Canada, ²University of Montreal, Montreal, QC, Canada, ³McGill University, Montreal, QC, Canada
*Purpose: Kidney transplantation is the optimal treatment for end-stage kidney disease. However, antibody-mediated rejection can lead to graft loss. The use of Precision Medicine (PM)…
2022 American Transplant Congress
Waitlisted and Transplant Patient Perspectives on Expanding Access to Deceased Donor Kidney Transplants
C. Rosaasen¹, N. Rosaasen², R. Mainra³, A. Trachtenberg⁴, J. Ho⁵, C. Parsons⁶, S. Delaney⁶, H. Mansell⁷
¹Johnson Shoyama School of Public Policy, University of Saskatchewan, Saskatoon, SK, Canada, ²Saskatchewan Transplant Program, Saskatchewan Health Authority, Saskatoon, SK, Canada, ³Division of Nephrology, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, ⁴, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁵Department of Internal Medicine and Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada, ⁶Canadian Blood Services, Edmonton, AB, Canada, ⁷University of Saskatchewan, Saskatoon, SK, Canada
*Purpose: A concerning number of kidneys (expanded donor criteria, extended criteria, or marginal kidneys) are discarded yearly, and novel solutions are needed to solve the…
2022 American Transplant Congress
Rapid Formalin-Fixed Deceased Donor Kidney Biopsy Protocol – A Proof Of Concept
M. R. Marvin¹, G. Chen², A. Kotru¹, C. Koo¹, P. Sanghi³, M. Moritz⁴, J. Clarke⁴, R. Hasz⁴
¹Transplant, Geisinger Medical Center, Danville, PA, ²Pathology, Geisinger Medical Center, Danville, PA, ³Transplant Nephrology, Geisinger Medical Center, Danville, PA, ⁴Gift of Life Donor Program, Philadelphia, PA
*Purpose: Reducing kidney discard is a major priority for the transplant community. While frozen section biopsies are the current standard, they are fraught with technical…